Thus, the inclusion of larger patient cohorts is imperative to advance our comprehension of HSP60’s involvement in breast carcinoma and shed light on the molecular mechanisms contributing to breast carcinoma onset. This evidence concerns the gene HSPD1 and breast carcinoma.